FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function

Biology of Blood and Marrow Transplantation

Volumn 11, Issue 1, 2005, Pages 23-34

  Chen, Wei ^a   Chan, Anissa S H ^a   Dawson, Amanda J ^a   Liang, Xueqing ^a   Blazar, Bruce R ^a   Miller, Jeffrey S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

CpG DNA; Dendritic cells; FLT3 ligand; NK cells; T lymphocytes

Indexed keywords

BLEOMYCIN; CD14 ANTIGEN; CD69 ANTIGEN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLT3 LIGAND; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; MITOXANTRONE; OLIGODEOXYNUCLEOTIDE DERIVATIVE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PREDNISONE; RITUXIMAB; VINBLASTINE; VINCRISTINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BREAST CANCER; CANCER IMMUNOTHERAPY; CANCER PATIENT; CELL ACTIVATION; CELL COUNT; CELL MATURATION; CELL MEDIATED CYTOTOXICITY; CELL STIMULATION; CELL SURFACE; CIRCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CPG ISLAND; DENDRITIC CELL; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FREQUENCY ANALYSIS; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNITY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MONOCYTE; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA CELL; STATISTICAL SIGNIFICANCE; STEM CELL MOBILIZATION; T LYMPHOCYTE;

ADULT; ANTIGEN PRESENTATION; BLOOD CELL COUNT; BREAST NEOPLASMS; CELL DIFFERENTIATION; CPG ISLANDS; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNITY; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOMA; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OLIGODEOXYRIBONUCLEOTIDES; T-LYMPHOCYTES;

EID: 11244327576     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2004.08.004     Document Type: Article

References (38)

1. J. Banchereau F. Briere C. Caux et al. Immunobiology of dendritic cells Annu Rev Immunol. 18 2000 767-811
2. N.C. Fernandez A. Lozier C. Flament et al. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo Nat Med. 5 1999 405-411
3. A. Moretta Natural killer cells and dendritic cells: Rendezvous in abused tissues Nat Rev Immunol. 2 2002 957-964
4. Y.J. Liu Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity Cell 106 2001 259-262
5. N. Kadowaki S. Ho S. Antonenko et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens J Exp Med. 194 2001 863-869
6. N. Kadowaki S. Antonenko Y.J. Liu Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c-type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN J Immunol. 166 2001 2291-2295
7. S.D. Lyman S.E. Jacobsen c-kit ligand and Flt3 ligand: Stem/progenitor cell factors with overlapping yet distinct activities Blood 91 1998 1101-1134
8. B. Blom S. Ho S. Antonenko Y.J. Liu Generation of interferon alpha-producing predendritic cells (Pre-DC)2 from human CD34(+) hematopoietic stem cells J Exp Med. 192 2000 1785-1796
9. M. Gilliet A. Boonstra C. Paturel et al. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor J Exp Med. 195 2002 953-958
10. J.S. Miller V. McCullar M. Punzel et al. Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells Blood 93 1999 96-106
11. H.J. McKenna K.L. Stocking R.E. Miller et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells Blood 95 2000 3489-3497
12. E. Maraskovsky K. Brasel M. Teepe et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified J Exp Med. 184 1996 1953-1962
13. B. Pulendran J. Lingappa M.K. Kennedy et al. Developmental pathways of dendritic cells in vivo: Distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand- treated mice J Immunol. 159 1997 2222-2231
14. M.R. Shurin P.P. Pandharipande T.D. Zorina et al. FLT3 ligand induces the generation of functionally active dendritic cells in mice Cell Immunol. 179 1997 174-184
15. B. Pulendran J.L. Smith G. Caspary et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo Proc Natl Acad Sci U S A 96 1999 1036-1041
16. R. Maldonado-Lopez T. De Smedt P. Michel et al. CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo J Exp Med. 189 1999 587-592
17. E. Maraskovsky E. Daro E. Roux et al. In vivo generation of human dendritic cell subsets by Flt3 ligand Blood 96 2000 878-884
18. B. Pulendran J. Banchereau S. Burkeholder et al. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo J Immunol. 165 2000 566-572
19. W. Chen S. Antonenko J.M. Sederstrom et al. Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors Blood 103 2004 2547-2553
20. J.S. Miller V. McCullar Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2 Blood 98 2001 705-713
21. H. Yu T.A. Fehniger P. Fuchshuber et al. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15 Blood 92 1998 3647-3657
22. S.G. Shaw A.A. Maung R.J. Steptoe et al. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy J Immunol. 161 1998 2817-2824
23. A.M. Krieg CpG motifs in bacterial DNA and their immune effects Annu Rev Immunol. 20 2002 709-760
24. H. Hemmi O. Takeuchi T. Kawai et al. A Toll-like receptor recognizes bacterial DNA Nature 408 2000 740-745
25. F. Takeshita C.A. Leifer I. Gursel et al. Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells J Immunol. 167 2001 3555-3558
26. G. Hartmann G.J. Weiner A.M. Krieg CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells Proc Natl Acad Sci U S A 96 1999 9305-9310
27. M. Bauer V. Redecke J.W. Ellwart et al. Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells J Immunol. 166 2001 5000-5007
28. B.R. Blazar A.M. Krieg P.A. Taylor Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients Blood 98 2001 1217-1225
29. B.J. Weigel N. Nath P.A. Taylor et al. Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses Blood 100 2002 4169-4176
30. C. Brunner J. Seiderer A. Schlamp et al. Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo J Immunol. 165 2000 6278-6286
31. K. Heckelsmiller S. Beck K. Rall et al. Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy Eur J Immunol. 32 2002 3235-3245
32. W. Chen A.S.H. Chan A.J. Dawson et al. CpG oligodeoxynucleotides activate human NK cells predominantly via an indirect mechanism through plasmacytoid dendritic cells: Keystone Symposia-J7 2003 (abstr. 116)
33. A. Krug S. Rothenfusser V. Hornung et al. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells Eur J Immunol. 31 2001 2154-2163
34. G. Hartmann J. Battiany H. Poeck et al. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells Eur J Immunol. 33 2003 1633-1641
35. V. Soumelis I. Scott F. Gheyas et al. Depletion of circulating natural type 1 interferon-producing cell in HIV-infected AIDS patients Blood 98 2001 906-912
36. M. Arpinati C.L. Green S. Heimfeld et al. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells Blood 95 2000 2484-2490
37. M. Rossi M. Arpinati D. Rondelli et al. Plasmacytoid dendritic cells: Do they have a role in immune responses after hematopoietic cell transplantation? Hum Immunol. 63 2002 1194-1200
38. E.K. Waller H. Rosenthal T.W. Jones et al. Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation Blood 97 2001 2948-2956